Company Filing History:
Years Active: 2000
Title: Sigrid Buhler: Innovating the Light-Controlled Synthesis of Oligonucleotides
Introduction:
In the realm of innovations and patents, Sigrid Buhler from Constance, DE has made significant contributions with her groundbreaking invention in the field of nucleoside derivatives. Her patent, titled "Nucleoside Derivatives with Photolabile Protective Groups," has paved the way for light-controlled synthesis of oligonucleotides on DNA chips. Let's explore her latest patents, career highlights, collaborations, and conclude with the impact of her work.
Latest Patents:
Sigrid Buhler holds one notable patent, which focuses on nucleoside derivatives with photo-unstable protective groups. These photolabile protective groups are represented by the general formula (I), encompassing various functional groups and bases, such as adenine, cytosine, guanine, thymine, and uracil. With the invention, Buhler enables the light-controlled synthesis of oligonucleotides on DNA chips.
Career Highlights:
Sigrid Buhler is associated with the esteemed Wolfgang Pfleiderer company, recognized for its contributions and advancements in the domain of nucleotide chemistry. As an integral member of the Wolfgang Pfleiderer team, Buhler has showcased her expertise and commitment to innovation in her patent. Her work has pushed the boundaries of possibilities in the realm of nucleoside derivatives.
Collaborations:
Within the Wolfgang Pfleiderer company, Sigrid Buhler has collaborated closely with her coworker, Wolfgang Pfleiderer. This collaboration signifies the collective effort of talented individuals in driving progress and ushering in new possibilities in their chosen field.
Conclusion:
Sigrid Buhler's patent on nucleoside derivatives with photolabile protective groups marks a significant breakthrough in the light-controlled synthesis of oligonucleotides on DNA chips. Her innovative work brings about new possibilities for DNA chip technologies, opening doors for enhanced research, diagnostics, and therapeutics in the biotechnology and medical fields. Sigrid Buhler's contribution to the field of innovations and patents is commendable, exemplifying the value of persistence, expertise, and collaboration in advancing scientific progress.